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1. Introduction 
1.1 Background 
Test materials of three levels of complexity have been developed as prototype reference 
materials for Mycobacterium tuberculosis (M. tuberculosis) (D1.3.1): TB Control Plasmid (Level 
1: Nucleic acid molecule); H37Rv genomic DNA (gDNA) (Level 2: Nucleic acid extract) and heat-
inactivated Mycobacterium bovis Bacillus Calmette–Guérin (BCG) in artificial sputum “BCG in 
artificial sputum” (Level 3: Whole microbe material).  BCG in artificial sputum test material 
requires extraction of gDNA prior to analysis using the Cetyltrimethylammonium bromide (CTAB) 
NaCl method (Soolingen and de Haas, 2001) which was found to be the optimum method in a 
comparison of different extraction approaches (D1.2.2 and D1.2.3).  
 
Potential higher order amplification-based methods for quantification of M. tuberculosis genome 
copies have been developed using PCR assays which are specific to two M. tuberculosis target 
genes: 16S ribosomal RNA (16S rRNA) and RNA polymerase beta sub-unit (rpoB).  These 
assays have been optimised for real-time quantitative PCR (qPCR) and digital PCR (dPCR) 
analysis (D1.5.2). 
 
1.2 Aims 
The aims of this inter-laboratory study are to assign values to test materials (plasmid or genome 
copies/μL) and to evaluate the reproducibility of potential higher order methods for tuberculosis 
(TB) quantification using dPCR.   
 
1.3 Objectives 
 Measurement of 16S rRNA and rpoB DNA copy numbers, in order to calculate the 
concentration of plasmid and TB genomic copies present in the three test materials.  
 Evaluation of the variability of measurements performed at each test laboratory in order 
to gather information on the repeatability and intermediate precision of the potential 
higher methods. 
 Evaluation of the comparability of dPCR measurements performed using two different 
platforms: (i) qdPCR 37k integrated fluidic circuit (IFC) arrays and BioMark PCR System 
(Fluidigm) (Section 5.3) and (ii) QX100 or QX200 Droplet Digital PCR System (Bio-Rad) 
(Section 5.4). 
 Comparison of measurements performed at three different laboratories in order to 
evaluate the reproducibility of measurements.  
 
1.4 Received materials and storage conditions 
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The below listed materials are distributed to participants: 
 TB Control Plasmid (4 tubes)  
 H37Rv gDNA (4 tubes)  
 BCG in artificial sputum (4 tubes)   
 20PP mixes (3 tubes): 
o UCL_16S (primers for BioMark) (100 μL) 
o UCL_16S (primers for QX100/QX200) (200 μL) 
o GN_rpoB1 (300 μL) 
 Sample Diluent (1 tube) 
 
Three units (tubes) of each test material are supplied to each laboratory for performing the study. 
An additional unit of each material is supplied for preliminary testing of methods.  16S rRNA and 
rpoB PCR assays (Section 4) are supplied as 20 solutions of primers and hydrolysis probe 
(“20PP”). Sample Diluent consisting of sonicated human gDNA (Cambio, Cat# CA-972-05) is 
provided as a concentrated stock (500 ng/μL, 500 μL) for preparation of working stocks (Section 
6).   
 
Upon receipt of samples, TB Control Plasmid and H37Rv gDNA test materials, 20 PP solutions 
and Sample Diluent stock solution are to be stored at -20°C.  BCG in artificial sputum should be 
stored at -80°C if available (if a -80°C freezer is not available, this material should be stored at -
20°C).   
 
1.5 Experimental design  
It is proposed that three independent analyses consisting of dilution (Section 6) and dPCR 
(Section 5) of each unit of test material (“test sample”) are to be performed for each dPCR 
platform (a total of six experiments) (Figure 1)  Each dPCR experiment consists of measurement 
of 16S rRNA and rpoB copy numbers in each test sample with two replicate reactions.  It is 
recommended that a minimum of six aliquots of each test sample are prepared initially in order to 
standardise the number of freeze-thaw cycles prior to each experiment. 
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Figure 1: Experimental design of TB test material analysis 
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2. Test materials 
2.1 Background 
Please see the document Deliverable D1.3.1 for further information on preparation and contents 
of test materials. Concentrations of TB Control Plasmid and H37Rv gDNA were initially 
determined by Qubit® (fluorometric dsDNA High Sensitivity binding assay) analysis (D1.3.1), 
however further information based on preliminary qPCR or dPCR analysis (BioMark platform) of 
the test materials is provided here in order to ensure that samples are analysed within the 
optimum range for dPCR analysis. 
 
2.2 TB Control Plasmid (nucleic acid molecule) 
Restriction digestion of 100 ng TB Control Plasmid was performed with HindIII and the linearised 
plasmid was diluted to a concentration of ~10
5
 copies/L in a background of sonicated human 
gDNA (25 ng/L).  Preliminary dPCR analysis estimated the mean concentration of plasmid DNA 
to be approximately 1.4  10
5
 copies/μL.  
 
2.3 H37Rv gDNA (nucleic acid extract) 
M. tuberculosis H37Rv gDNA obtained from ATCC was diluted in sonicated human gDNA (25 
ng/L) to a concentration of ~10
5
 copies/L.  Initial dPCR analysis indicated this material to have 
a concentration of approximately 6.8  10
4
 copies/μL.  
 
2.4 BCG in artificial sputum (whole microbe preparation) 
M. bovis BCG was grown in liquid culture and a suspension of mycobacteria spiked into artificial 
sputum matrix (ASM) in 1 mL aliquots. The number of colony-forming units (CFU) per mL of ASM 
was ascertained by solid agar counting and a mean value ( 95% confidence interval) of 1.1  
10
7
 ( 1.3  10
6
) CFU/mL ASM obtained. gDNA was extracted from ten sample units using the 
CTAB method (Section 3) and analysed for rpoB copy number by qPCR and dPCR. The average 
concentration was 1.3  10
7
 genomic copies/unit with an inter-vial CV of 13%. 
 
2.5 Test material stability 
Suitability of the BCG in artificial sputum material for shipment was confirmed by performing a 
short-term stability study. Units of the test material (n = 3) were incubated on dry ice, +4°C and 
+40°C for 7 and 14 days compared to storage at the reference temperature of -80°C. gDNA was 
extracted from test units using CTAB NaCl (Section 3) and rpoB genomic equivalents measured 
by qPCR using an H37Rv gDNA standard curve. Analysis of variance (ANOVA) indicated no 
statistically significant differences between treatments (p > 0.05).   
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3. Protocol for gDNA extraction from BCG in artificial sputum 
3.1 Samples 
 BCG in artificial sputum test material (Section 2) 
 
3.2 Equipment required 
 Biosafety cabinet 
 Fume hood 
 Centrifuge, max speed > 10,000 g 
 Water bath/heating block at 37°C 
 Water bath at 65°C 
 
3.3 Materials 
 1% Virkon (or similar virucidal disinfectant) 
 
3.4 Reagents  
 10 mg/mL lysozyme (such as Sigma, Cat# L3790-10X1ML)  
 CTAB/NaCl buffer (700 mM NaCl, 10% w/v CTAB, see Appendix I) 
 SDS (10% in distilled H2O, e.g. Sigma: 71736) 
 Proteinase K (20 mg/mL) 
 NaCl (5M, see Appendix I) 
 Chloroform/Isoamyl alchohol (24:1 v/v, see Appendix I) 
 Isopropanol (Molecular biology grade, >99.5% v/v, stored at < -20°C) 
 Ethanol (70% v/v in distilled H2O, stored at < -20°C) 
 1 Tris-EDTA (TE) solution 
 
3.5 Notes 
Samples should not be vortexed at any point during the extraction, as this could shear the gDNA. 
Aliquots of reagents required in the biosafety cabinet should be prepared, with the remainder 
discarded after use. 
 
3.6 Method 
Note: The required volumes (+ dead volume) of reagents marked with * (below) should be 
aliquotted into clean vials for use in the biosafety cabinet. Any remaining reagent in the aliquot 
should be discarded. 
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1. Thaw the required number of vials of frozen, heat killed BCG in artificial sputum. Briefly 
centrifuge vials and transfer to a biosafety cabinet.  
2. Add 50 µL of 10 mg/mL lysozyme* and mix gently by stirring with the pipette. 
3. Wipe vials with 1% Virkon before removing from the biosafety cabinet, and incubate 
overnight in a water bath (or heating block) set at 37°C.  
4. Return the vials to the biosafety cabinet and set the water bath to 65°C. Pre-warm the 
CTAB/NaCl buffer to 65°C. 
5. Add 70 µL 10% SDS* and 5 µL 20 mg/mL proteinase K* to each sample vial. Mix gently 
by stirring with the pipette tip.  
6. Wipe vials with 1% Virkon, then relocate to the water bath and incubate at 65°C for 10 
minutes. 
7. Spin vials briefly and return to the biosafety cabinet.  
8. Add 100 µL 5M NaCl* to each vial, followed by 100 µL of pre-warmed CTAB/NaCl 
buffer*. Mix gently with the pipette. 
9. Wipe vials with 1% Virkon, remove to the water bath and incubate at 65°C for 10 
minutes. 
10. Spin vials briefly and relocate to a fume hood. 
11. Add 750 µL of chloroform/isoamyl alcohol (24:1 v/v). Mix by inverting the tubes at least 
10 times. 
12. Remove samples from the fume hood and spin vials at 10,000 g for 5 minutes. 
13. Appropriately label sterile, nuclease-free 1.5 mL vials and aliquot 450 µL of ice cold (-
20°C) 100% Isopropanol to each. 
14. In the fume hood, carefully transfer upper (aqueous) supernatant layers from step 12 into 
the appropriately labelled vials prepared in step 13. Take care not to disturb the 
aqueous/organic interface when removing supernatant. Discard organic layers. 
15. Chill sample at -20 °C for 30 minutes. 
16. Spin samples at 10,000 g for 15 minutes at ambient temperature. 
17. Remove and discard the supernatants and wash pellets with 1 mL of ice-cold (-20°C) 
70% Ethanol. Invert gently. 
18. Spin vials at 10,000 g for 5 minutes at ambient temperature. Remove and discard as 
much ethanol as possible without disturbing the pellets.  
19. Dry pellets by incubating with the lids open, in a heating block set at 65°C, until all of the 
ethanol has evaporated. 
20. Rehydrate pellets in 200 µL TE buffer overnight at 4°C. 
21. Prepare aliquots of gDNA extracted from BCG in artificial sputum and store extracts at -
20°C.
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4. PCR assay information 
4.1 Oligonucleotide sequences and information 
Participating laboratories are provided with a 20PP mix containing primers and probe for the two assays to be used for the inter-laboratory study.  
Assays UCL_16S (Table 1) and GN_rpoB1 (Table 2) are to be used to measure copy number of the TB target genes 16S rRNA and rpoB 
respectively. Further information is contained in D1.5.2 “Measurement procedures for detection and quantification of the model system”.  
 
Table 1: UCL_16S assay information  
 
Table 2: GN_rpoB1 assay information 
 
It is recommended that single-use aliquots of the 20PP mixes are prepared in order to multiple freeze-thaw cycles of the reagents.
Primer/probe name Sequence (5' - 3') Length Tm (°C) Label 
Amplicon size 
(bp) 
Reference 
UCL_16S_F GTGATCTGCCCTGCACTTC 19 63.6 
 
106 
Honeyborne et 
al., 2011 
UCL_16S_R ATCCCACACCGCTAAAGCG 19 67.2 
 
UCL_16S_P AGGACCACGGGATGCATGTCTTGT 24 73.4 FAM/BHQ1 
Primer/probe name Sequence (5' - 3') Length Tm (°C) Label 
Amplicon size 
(bp) 
Reference 
RPOB_FW1 CAAAACAGCCGCTAGTCCTAGTC 23 65 
 
84 In-house assay RPOB_REV1 AAGGAGACCCGGTTTGGC 18 66.3 
 
RPOB_PROBE1 AGTCGCCCGCAAAGTTCCTCGAA 23 75.1 FAM/BHQ1 
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5. dPCR analysis 
5.1 dPCR experimental design 
Each experiment (Figure 2) consists of independent dilution and dPCR analysis of all three units 
of each test material (a total of nine test samples).  For each experiment, 36 reactions are 
required for dPCR analysis of all test samples with duplicate assays to 16S rDNA and rpoB. The 
remaining 12 panels of each qdPCR 37k array (BioMark) or ddPCR 96-well plate (QX100/200), 
respectively, should consist of no template controls (NTC) reactions: (1) Sample diluent 
(sonicated human genomic DNA, 25 ng/μL) (n = 3 for each assay) and (2) nuclease-free water (n 
= 3 for each assay).  
 
 
Figure 2: dPCR experimental design  
 
Note: The UCL_16S assay was validated using a final concentration of 200 nM for the BioMark 
platform whereas a final primer concentration of 300 nM was found to be optimal for the QX100.  
Therefore separate 20×PP mixes are provided for each platform. 
 
5.2 Templates 
It is recommended that template dilution (Section 6) is performed after PCR mastermix 
preparation in order to avoid contamination of reaction mastermixes.  
Following dilution, test samples are estimated to contain the following concentrations based on 
preliminary analysis of rpoB copy number. The concentrations have been chosen in order to 
result in a dPCR   value of ~ 1.0.  
 Diluted TB control plasmid (7.0  10
3
 copies/μL)  
Stock concentration
Gravimetric 
dilution
Plasmid
P1-3
20-fold dilution
9 test samples (n = 2)
Sample diluent NTC (n = 3)
Nuclease-free water NTC (n = 3)
2 assays (UCL_16S rRNA and GN_rpoB1)
H37Rv gDNA
H1-3
BCG extract
B1-3
Working 
concentration
(where x = 
dilution for 
Experiment
1-6) :
P1.Dx P2.Dx P3.Dx H1.Dx H2.Dx B1.Dx B2.Dx B3.DxH3.Dx
Reactions for each 
experiment
10-fold dilution10-fold dilution
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 Diluted H37Rv gDNA (6.8  10
3
 genome copies/μL)  
 Diluted gDNA extracted from BCG in artificial sputum (6.5  10
3
  copies/unit)  
 
5.3 BioMark dPCR protocol 
5.3.1 Materials 
 qdPCR 37K IFC (Integrated Fluidic Circuit; Fluidigm, Cat# 100-6152) 
 Control Line Fluid Kit (Fluidigm, Cat# 89000020) 
5.3.2 Reagents 
 Gene Expression Master Mix (Applied Biosystems, Cat# 4369016) 
 GE Sample Loading Reagent (Fluidigm, Cat# 8500746) 
 Nuclease-free water (such as Ambion, Cat# AM9937) 
 Sample Diluent: Sonicated human genomic DNA (25 ng/μL, prepared from stock 
solution)  
 UCL_16S assay 20PP mix BIOMARK ONLY (provided)  
 GN_rpoB1 assay 20PP mix (provided) 
5.3.3 Reaction mix preparation  
For each panel, a 10 μL reaction is prepared to allow sufficient excess for pipetting 6 μL into 
each sample inlet and to avoid inclusion of air bubbles into the microfluidic circuit.  
Tables 3 and 4 describe the composition of a single dPCR assay and recommended scaled 
volumes for preparation of a reaction mastermix sufficient for each experiment. Further details for 
16S rDNA and rpoB assays are included in Section 4. 
 
Table 3: BioMark dPCR assay and mastermix composition (UCL_16S assay) 
Component [Final] 
Volume 1 reaction 
(μL) 
Volume ½ array 
(30 reactions) (μL) 
Gene Expression Master Mix 1 5.0 150.0 
Sample Loading Reagent 2 1.0 30.0 
Forward primer 200 nM 
0.5 (20 PP) 15.0 (20 PP) Reverse primer 200 nM 
Probe [FAM/NFQ] 200 nM 
Nuclease-free water N/A 1.5 45.0 
DNA  N/A 2.0  
  Total (μL) 10.0 210.0 
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Table 4: BioMark dPCR assay and mastermix composition (GN_rpoB1 assay) 
Component [Final] 
Volume 1 reaction 
(μL) 
Volume ½ array 
(30 reactions) (μL) 
Gene Expression Master Mix 1 5.0 150.0 
Sample Loading Reagent 2 1.0 30.0 
Forward primer 900 nM 
0.5 (20 PP) 15.0 (20 PP) Reverse primer 900 nM 
Probe [FAM/NFQ] 200 nM 
Nuclease-free water N/A 1.5 45.0 
DNA  N/A 2.0  
  Total (μL) 10.0 210.0 
 
Replicate reactions (n = 2) are to be prepared for each diluted test sample. For recommended 
dilution factors see Section 6. 
5.3.4 Instrument set-up 
Priming and loading of qdPCR 37K IFCs are to be performed as per manufacturer’s standard 
protocol. The following information is to be specified during dPCR set-up using BioMark Data 
Collection software: 
 Detector to be selected as ‘Single Probe’ and ‘FAM-MGB’.  
 Thermal cycling conditions (Table 5): ‘10min-Hot-start 40 cycles’ (default protocol) 
 
Table 5: BioMark dPCR thermal cycling conditions  
Cycles Time 
Temp 
(°C) 
1 2 min 50 
1 10 min 95 
40 
15 sec 95 
60 sec 60 
 
5.3.5 BioMark data analysis 
It is recommended that positive amplifications are counted between PCR cycles 20 and 40 with 
manual Cq threshold setting for each assay (“Detector”) and linear baseline correction. Please 
report Cq threshold, quality threshold, positive amplifications per panel (“Count”) and copy 
number per panel (“Estimated targets”) from each experiment in the data submission 
spreadsheet.  
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5.4 QX100 droplet dPCR protocol 
5.4.1 Materials 
 DG8 cartridge (Bio-Rad, Cat# 186-4008) 
 Droplet generator oil (Bio-Rad, Cat# 290-10430) 
 Pierceable Foil Heat Seal (Bio-Rad, Cat# 181-4040) 
5.4.2 Reagents 
 ddPCR Supermix for Probes (Bio-Rad, Cat# 186-3010) 
 Nuclease-free water (such as Ambion, Cat# AM9937) 
 Sample Diluent: Sonicated human genomic DNA (25 ng/μL, see Section 6)  
 UCL_16S assay 20PP mix BIORAD ONLY (provided)  
 GN_rpoB1 assay 20PP mix (provided) 
5.4.3 Reaction mix preparation 
Table 6 and Table 7 describe the composition of a single droplet dPCR assay and recommended 
scaled volumes for preparation of reaction mastermix sufficient for each experiment. Further 
details for 16S rDNA and rpoB assays are included in Section 4.  
 
Table 6: QX100 dPCR assay and mastermix composition (UCL_16S assay) 
Component [Final] 
Volume 1 reaction 
(μL) 
Volume 30 reactions 
(μL) 
ddPCR Supermix 1 10.0 300.0 
Forward primer 300 nM 
1.0 (20 PP mix) 30.0 (20 PP mix) Reverse primer 300 nM 
Probe [FAM/NFQ] 200 nM 
Nuclease-free water N/A 5.0 150.0 
DNA N/A 4.0  
 
Total  (μL) 20.0 420.0 
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Table 7: QX100 dPCR assay and mastermix composition (GN_rpoB1 assay) 
Component [Final] 
Volume 1 reaction 
(μL) 
Volume 30 reactions 
(μL) 
ddPCR Supermix 1 10.0 300.0 
Forward primer 900 nM 
1.0 (20 PP mix) 30.0 (20 PP mix) Reverse primer 900 nM 
Probe [FAM/NFQ] 200 nM 
Nuclease-free water N/A 5.0 150.0 
DNA N/A 4.0  
 
Total  (μL) 20.0 420.0 
 
Typically, individual reactions containing both PCR mastermix and sample template were 
prepared to include a 10% excess (total volume 22 μL/reaction) to allow for pipetting 20 μL into 
the DG8 cartridge. Droplet generation should be performed using the DG according to the 
manufacturer’s standard procedure. 40 μL of droplets was pipetted into wells of a 96-well plate 
and was sealed with a foil sheet using the BioRad PX1 PCR plate sealer for 6 seconds at 170°C. 
 
Replicate reactions (n = 2) are to be prepared for each diluted test sample. For recommended 
dilution factors see Section 6. 
5.4.4 Instrument set-up 
PCR was performed by the coordinating laboratory using a C1000 Touch Thermal Cycler (Bio-
Rad) using the cycling conditions below (Table 8): 
Table 8: Droplet dPCR thermal cycling conditions 
Step 
# of 
cycles 
Time 
Temp 
(°C) 
Enzyme activation 1 10 min 95 
Denaturation 
40 
30 sec 94 
Annealing/extension* 1 min 60 
Enzyme Heat Kill 1 10 min 98 
Hold (optional) 1 ∞ 4 
         * Ramp Rate settings to ~2.5 
o
C/sec.            Heated lid: 105 °C 
5.4.5 Data analysis 
For each reaction, please report number of positive droplets and total number of accepted 
droplets from each experiment in the data submission spreadsheet.  
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6.   Sample preparation for dPCR analysis 
6.1 Sample nomenclature 
Test materials are given the following alphabetical abbreviations (Figures 1 and 2): TB Control 
Plasmid (P); H37Rv gDNA (H) and BCG in artificial sputum (B). Each unit of test material is 
designated numerically: for example, TB control plasmid unit 1 is given the nomenclature P1.  A 
dilution of the test sample for Experiment x is designated P1.Dx (e.g. dilution of sample P1 for 
Experiment is designated P1.D1). 
 
6.2 Preparation of test sample aliquots  
Each dPCR experiment consists of an independent dilution prior to dPCR. Therefore, aliquots of 
each TB control plasmid (P), H37Rv gDNA (H) test sample and gDNA extracted from BCG in 
artificial sputum (B) should be prepared prior to the first experiment and re-frozen at -20µC.  For 
example, six aliquots of 6 µL could be prepared to allow 5 µL to be used for dilution for each 
dPCR experiment.  Aliquots can be designated P1.1-P1.6 (Figure 1).  
 
6.3 Sample Diluent preparation 
A working stock of sample diluent (25 ng/µL) should be prepared by 20-fold dilution of the stock 
solution (500 ng/µL) with nuclease-free water.  Approximately 700 µL of Sample Diluent (working 
solution) is required for each experiment for test sample dilution and dPCR NTCs (n = 3 per 
assay; n = 6 per experiment).  
 
6.4 Test sample dilution for dPCR  
All test samples require dilution prior to dPCR analysis. Dilution should be performed 
gravimetrically. Test sample dilution should be performed on the same day as dPCR analysis. 
Dilution factors are the same for both BioMark dPCR (designated Experiments 1-3, Figure 1) 
(Section 5.3) and QX100/200 droplet dPCR (designated Experiments 4-6, Figure 1) (Section 5.4) 
analysis. Please note the template nomenclature used in the submission spreadsheets.  
 
Tables for recording mass measurements are available in the data submission spreadsheet. An 
instrument accurate to 0.001 g should be used. It is recommended that test samples are mixed 
with Sample Diluent by brief (~1 second) vortexing to ensure that diluted templates are 
thoroughly homogenised before addition to reaction mixes. 
6.4.1 TB control plasmid 
TB plasmid at the provided stock concentration should be diluted in Sample Diluent by a factor of 
20 by mixing 5 μL of test material with 95 μL of diluent.  
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6.4.2 H37Rv gDNA 
H37Rv at the provided stock concentration should be diluted in Sample Diluent by a factor of 10 
by mixing 5 μL of test material in 45 μL of diluent.  
6.4.3 gDNA extracted from BCG in artificial sputum 
It is recommended that gDNA extracted from BCG in artificial sputum using the protocol provided 
in Section 3 is diluted 10 fold prior to dPCR by mixing 5 μL with 45 μL Sample Diluent. 
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7.   Preparation of CTAB extraction reagents 
7.1 CTAB/NaCl solution 
Dissolve 4.1 g of NaCl in 20 mL of distilled H2O. Add 10 g CTAB (Cetyltrimethylammonium 
bromide 99+%) and heat to 65 °C until dissolved. Make up volume to 100 mL with distilled water 
and autoclave at 121 °C for 20 minutes. Store at 4 °C for up to 6 months. 
 
7.2 NaCl (5M) 
Add 5.84 g of NaCl to a 50 mL Duran bottle, or equivalent. Make up volume to 20 mL with 
distilled water. Heat to 65 °C and mix until dissolved (this may take hours). Autoclave at 121 °C 
for 20 minutes. Store at ambient temperature for up to  12 months. Note: This method may not 
scale up effectively, as the NaCl does not dissolve completely. If more volume is required, 
multiply the preparations and pool before autoclaving. 
 
7.3 Chloroform/ Isoamyl alcohol 
To 48 mL of Chloroform (ACS reagent grade, >99.8%), add 2 mL of Isoamyl alcohol (GLC, 98+ 
%). Mix thoroughly by shaking vigorously for 5 seconds. 
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